Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cellulose sulfate gel for vaginal HIV prevention
NCT00153777Phase 3Terminated
- Sponsor
- CONRAD
- Start
- Jul 2005
- Modality
- Polysaccharide
- Countries
- 4
01
Overview
Phase 3, randomised, triple-blind trial of cellulose sulfate in human immunodeficiency virus infection (HIV), gonorrhea and Chlamydia trachomatis infection (CT), sponsored by CONRAD. Primary endpoint: Combined incidence of HIV-1 and HIV-2 at 1 year. Started Jul 2005; status: terminated.
02
Drugs
cellulose sulfate
03
Conditions
human immunodeficiency virus infection (HIV)gonorrheaChlamydia trachomatis infection (CT)
Beyond the preview
Go deeper on NCT00153777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00153777.